113 related articles for article (PubMed ID: 17995578)
1. Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients.
Takahashi N; Kojima T; Ogawa H; Ishiguro N
Nephrology (Carlton); 2007 Dec; 12(6):539-45. PubMed ID: 17995578
[TBL] [Abstract][Full Text] [Related]
2. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
Ueda M; Inaba M; Okuno S; Maeno Y; Ishimura E; Yamakawa T; Nishizawa Y
Life Sci; 2005 Jul; 77(10):1130-9. PubMed ID: 15978265
[TBL] [Abstract][Full Text] [Related]
3. Close association between parathyroid hormone and left ventricular function and structure in end-stage renal failure patients under maintenance hemodialysis.
Nasri H; Baradaran A; Naderi AS
Acta Med Austriaca; 2004 Aug; 31(3):67-72. PubMed ID: 15515479
[TBL] [Abstract][Full Text] [Related]
4. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
Nasri H; Kheiri S
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
[TBL] [Abstract][Full Text] [Related]
5. Parathyroid hormone contributes to variations in blood morphology in diabetic and non diabetic patients treated with continuous ambulatory peritoneal dialysis.
Grzegorzewska AE; Mariak I
Adv Perit Dial; 2001; 17():5-9. PubMed ID: 11510296
[TBL] [Abstract][Full Text] [Related]
6. Glycaemic control and serum intact parathyroid hormone levels in diabetic patients on haemodialysis therapy.
Murakami R; Murakami S; Tsushima R; Ueda C; Mikami K; Ebina T; Kumasaka R; Nakamura N; Okumura K
Nephrol Dial Transplant; 2008 Jan; 23(1):315-20. PubMed ID: 17956892
[TBL] [Abstract][Full Text] [Related]
7. [Clinical evaluation of osteocalcin in chronic hemodialysis patients].
Nishio S; Hayashi S; Yoshihara H; Kobayagawa H
Hinyokika Kiyo; 1989 Nov; 35(11):1839-45. PubMed ID: 2618881
[TBL] [Abstract][Full Text] [Related]
8. Effect of bed rest during pregnancy on bone turnover markers in pregnant and postpartum women.
Kaji T; Yasui T; Suto M; Mitani R; Morine M; Uemura H; Maeda K; Irahara M
Bone; 2007 Apr; 40(4):1088-94. PubMed ID: 17229597
[TBL] [Abstract][Full Text] [Related]
9. Serum osteoprotegerin level is lower in peritoneal dialysis patients than in hemodialysis ones.
Grzegorzewska AE; Młot M
Rocz Akad Med Bialymst; 2004; 49():193-6. PubMed ID: 15631342
[TBL] [Abstract][Full Text] [Related]
10. Hyperparathyroid bone disease in diabetic renal failure.
Cundy TF; Humphreys S; Watkins PJ; Parsons V
Diabetes Res; 1990 Aug; 14(4):191-6. PubMed ID: 2132193
[TBL] [Abstract][Full Text] [Related]
11. [Biochemical markers of age-related changes in bones turnover and bone mineral density in healthy Chinese men].
Jiang YX; Tang SY; Wu XP; Yang LF; Liao EY
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2008 Jan; 33(1):53-6. PubMed ID: 18245905
[TBL] [Abstract][Full Text] [Related]
12. Modulation of osteoblast activity by serum from diabetic and non-diabetic patients on hemodialysis: a three-dimensional culture study.
Serrano S; Mariñoso ML; Nacher M; Torres A; Cuevas X; Loreta J; Munné A; Diez A
J Nephrol; 2004; 17(3):369-76. PubMed ID: 15365956
[TBL] [Abstract][Full Text] [Related]
13. [Low dose estrogen replacement therapy (ERT) for postmenopausal hemodialysis (HD) patients].
Hamano T; Fujii N; Ito T; Imai E; Mikami S; Katayama M; Obi Y
Clin Calcium; 2005 Sep; 15 Suppl 1():161-6; discussion 166. PubMed ID: 16279020
[TBL] [Abstract][Full Text] [Related]
14. Bone mineral density and bone metabolism in hemodialysis patients. Correlation with PTH, 25OHD3 and leptin.
Polymeris A; Doumouchtsis K; Grapsa E
Nefrologia; 2012; 32(1):73-8. PubMed ID: 22130208
[TBL] [Abstract][Full Text] [Related]
15. The effects of diabetes mellitus and diabetic nephropathy on bone and mineral metabolism in T2DM patients.
Chen H; Li X; Yue R; Ren X; Zhang X; Ni A
Diabetes Res Clin Pract; 2013 May; 100(2):272-6. PubMed ID: 23522918
[TBL] [Abstract][Full Text] [Related]
16. Glucose-added dialysis fluid prevents asymptomatic hypoglycaemia in regular haemodialysis.
Burmeister JE; Scapini A; da Rosa Miltersteiner D; da Costa MG; Campos BM
Nephrol Dial Transplant; 2007 Apr; 22(4):1184-9. PubMed ID: 17272314
[TBL] [Abstract][Full Text] [Related]
17. [Clinical significance of PTH (1-84) and PTH (7-84) in patients with predialysis chronic renal failure in relation to bone metabolism markers].
Tsuchida T; Ishimura E; Hirowatari K; Matsumoto N; Jono S; Miki T; Inaba M; Nishizawa Y
Clin Calcium; 2005 Sep; 15 Suppl 1():156-60; discussion 160. PubMed ID: 16272650
[TBL] [Abstract][Full Text] [Related]
18. Bone alkaline phosphatase besides intact parathyroid hormone in hemodialysis patients--any advantage?
Jorge C; Gil C; Possante M; Silva E; Andrade R; Santos N; Cruz A; Teixeira R; Ferreira A
Nephron Clin Pract; 2005; 101(3):c122-7. PubMed ID: 16015001
[TBL] [Abstract][Full Text] [Related]
19. An automated 'bio-intact' PTH assay: a step towards standardisation and improved correlation with parathyroid function in renal disease.
Savoca R; Bock A; Kraenzlin ME; Schmid HR; Huber AR
Clin Chim Acta; 2004 May; 343(1-2):167-71. PubMed ID: 15115690
[TBL] [Abstract][Full Text] [Related]
20. Diabetic retinopathy is a poor predictor of type of nephropathy in proteinuric type 2 diabetic patients.
Prakash J; Lodha M; Singh SK; Vohra R; Raja R; Usha
J Assoc Physicians India; 2007 Jun; 55():412-6. PubMed ID: 17879494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
